secwatch.observer — SEC 8-K summary
======================================

Issuer:     SEELOS THERAPEUTICS, INC. (—)
CIK:        0001017491
Form:       8-K
Filed at:   2022-11-23T23:59:59+00:00
Accession:  0001136261-22-000351
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Seelos receives Nasdaq non-compliance notice for bid price below $1.00
----------------------------------------------------------------------

- On Nov 21, 2022, Nasdaq notified Seelos that its common stock bid price closed below $1.00 for 30 consecutive business days.
- Company has 180 calendar days, until May 22, 2023, to regain compliance by closing at $1.00+ for 10 consecutive business days.
- If not compliant by May 22, 2023, Seelos may be eligible for an additional 180-day period if it meets other listing standards.
- Failure to regain compliance could result in delisting from Nasdaq Capital Market; company may appeal but no assurance.
- Seelos intends to monitor bid price and consider options including reverse stock split to cure deficiency.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1017491/000113626122000351/0001136261-22-000351-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1017491/000113626122000351/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001136261-22-000351

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer